Table_5_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx by Jessica L. Petrick (11413508)

Image_2_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”

Image_1_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”

Table_6_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx by Jessica L. Petrick (11413508)

Table_1_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx by Jessica L. Petrick (11413508)

Table_8_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx by Jessica L. Petrick (11413508)

Table_7_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx by Jessica L. Petrick (11413508)

Image_3_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”

Image_5_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.pdf by Jessica L. Petrick (11413508)

Image_4_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”

Image_1_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.pdf by Jessica L. Petrick (11413508)

Pancreatic cancer cells and ARG2-expressing CAFs. by Yoshinori Ino (284073)

“…<p>(A) ARG2-expressing CAFs do not support proliferation of pancreatic cancer cells. …”

Supplementary file 1_Therapeutic potential of formononetin in cirrhotic portal hypertension: modulating hepatic fibrosis, macrophage polarization, and lymphangiogenesis.doc by Zhenghao Wu (9732511)

“…</p>Methods<p>In vivo experiments, bile duct ligation (BDL) induced PHT models were conducted in rats, followed by a 4-week FN treatment (50 mg/kg/day) administered via gavage. …”

Image_4_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.pdf by Jessica L. Petrick (11413508)

Image 1_Functional trait recovery through backcross breeding in blister rust–resistant hybrid white pines (Pinus strobus × Pinus wallichiana).png by Lahcen Benomar (6320867)

“…</p>Methods<p>We assessed changes in photosynthetic-related traits, as well as needle morphology and resistance to xylem cavitation of eastern white pine and Himalayan blue pine, and their hybrids with varying levels of white pine parentage ranging from 50 to 87.5%.</p>Results and discussion<p>Needle length and specific leaf area (SLA) decreased linearly by increasing eastern white pine parentage; inversely, needle density increased by increasing eastern white pine parentage. …”

Table_2_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx by Jessica L. Petrick (11413508)

Image_3_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.pdf by Jessica L. Petrick (11413508)

Consumption of antibiotics in Chinese public general tertiary hospitals (2011-2014): Trends, pattern changes and regional differences by Xiaoyuan Qu (5171666)

“…<div><p>Background</p><p>China has a high rate of antibiotic use. The Chinese Ministry of Health (MOH) established the Center for Antibacterial Surveillance (CAS) to monitor the use of antibacterial agents in hospitals in 2005. …”

Image1_Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms.TIF by Qian Wang (32718)

“…<p>Cholestasis is a clinical syndrome triggered by the accumulation and aggregation of bile acids by subsequent inflammatory responses. …”

Table_4_Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018.xlsx by Jessica L. Petrick (11413508)